These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23345133)

  • 21. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T; Yoshida S
    Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
    Kornfeld SF; Lynch-Godrei A; Bonin SR; Gibeault S; De Repentigny Y; Kothary R
    PLoS One; 2016; 11(2):e0149201. PubMed ID: 26886550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration.
    Xiao L; Hu C; Yang W; Guo D; Li C; Shen W; Liu X; Aijun H; Dan W; He C
    Glia; 2013 Dec; 61(12):2078-99. PubMed ID: 24123220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
    Mi S; Lee X; Hu Y; Ji B; Shao Z; Yang W; Huang G; Walus L; Rhodes K; Gong BJ; Miller RH; Pepinsky RB
    Nat Med; 2011 Jul; 17(7):816-21. PubMed ID: 21725297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium Signaling in the Oligodendrocyte Lineage: Regulators and Consequences.
    Paez PM; Lyons DA
    Annu Rev Neurosci; 2020 Jul; 43():163-186. PubMed ID: 32075518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
    Oluich LJ; Stratton JA; Xing YL; Ng SW; Cate HS; Sah P; Windels F; Kilpatrick TJ; Merson TD
    J Neurosci; 2012 Jun; 32(24):8317-30. PubMed ID: 22699912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Protein Tyrosine Phosphatase Shp2 Regulates Oligodendrocyte Differentiation and Early Myelination and Contributes to Timely Remyelination.
    Ahrendsen JT; Harlow DE; Finseth LT; Bourne JN; Hickey SP; Gould EA; Culp CM; Macklin WB
    J Neurosci; 2018 Jan; 38(4):787-802. PubMed ID: 29217681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiology of Oligodendroglia.
    Butt AM; Papanikolaou M; Rivera A
    Adv Exp Med Biol; 2019; 1175():117-128. PubMed ID: 31583586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin.
    Mitew S; Hay CM; Peckham H; Xiao J; Koenning M; Emery B
    Neuroscience; 2014 Sep; 276():29-47. PubMed ID: 24275321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo.
    Kim JY; Sun Q; Oglesbee M; Yoon SO
    J Neurosci; 2003 Jul; 23(13):5561-71. PubMed ID: 12843257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function.
    Matute C; Palma A; Serrano-Regal MP; Maudes E; Barman S; Sánchez-Gómez MV; Domercq M; Goebels N; Dalmau J
    Ann Neurol; 2020 May; 87(5):670-676. PubMed ID: 32052483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.
    Manning SM; Talos DM; Zhou C; Selip DB; Park HK; Park CJ; Volpe JJ; Jensen FE
    J Neurosci; 2008 Jun; 28(26):6670-8. PubMed ID: 18579741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
    Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
    Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease.
    Spitzer S; Volbracht K; Lundgaard I; Káradóttir RT
    Neuropharmacology; 2016 Nov; 110(Pt B):574-585. PubMed ID: 27346208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligodendrocytes and myelin.
    McLaurin JA; Yong VW
    Neurol Clin; 1995 Feb; 13(1):23-49. PubMed ID: 7739504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinergic signaling in oligodendrocyte development and function.
    Welsh TG; Kucenas S
    J Neurochem; 2018 Apr; 145(1):6-18. PubMed ID: 29377124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
    Rinholm JE; Vervaeke K; Tadross MR; Tkachuk AN; Kopek BG; Brown TA; Bergersen LH; Clayton DA
    Glia; 2016 May; 64(5):810-25. PubMed ID: 26775288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in Oligodendrocyte Progenitor Cells Affects Postnatal Myelination in Mice.
    Cheli VT; Santiago González DA; Namgyal Lama T; Spreuer V; Handley V; Murphy GG; Paez PM
    J Neurosci; 2016 Oct; 36(42):10853-10869. PubMed ID: 27798140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sending mixed signals: bone morphogenetic protein in myelination and demyelination.
    See JM; Grinspan JB
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):595-604. PubMed ID: 19458544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.